Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Health Care Workforce Real-Time Data Dashboard Act
Client: SJ MEDCONNECT · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the use of real-time data information in graduate medical education; Issues related to S. 3038 - Health Care Workforce Real-Time Data Dashboard Act.
Health Care Workforce Real-Time Data Dashboard Act
Client: SJ MEDCONNECT · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the use of real-time data information in graduate medical education, including S. 3038 - Health Care Workforce Real-Time Data Dashboard Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to the use of real-time data information in graduate medical education, including S. 3038 - Health Care Workforce Real-Time Data Dashboard Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Source: Senate LDA
| EMED, LLC |
| 4 |
| 2021–2022 |
| EUROAPI | 4 | 2023 |
| SIGNATURE SCIENCE, LLC | 4 | 2024–2025 |
| UNIVERSITY OF LOUISVILLE | 4 | 2021–2022 |
| GAP INC. | 3 | 2021–2022 |
| INARI MEDICAL | 3 | 2021–2023 |
| Infineon Technologies Americas Corp. | 3 | 2021 |
| QNOVIA, INC. | 3 | 2023–2024 |
| TRANSMEDICS GROUP, INC. | 3 | 2026 |
| AHS MANAGEMENT COMPANY, INC | 2 | 2022 |
| BRADLEY LANE INVESTMENT COMPANY | 2 | 2022 |
| CENTRIENT PHARMACEUTICALS LLC | 2 | 2022 |
| CONSTELLIS HOLDINGS, LLC | 2 | 2023 |
| SUNNY GLEN CHILDREN'S HOME | 2 | 2022 |
| CITY OF LAREDO, TEXAS | 1 | 2023 |
| FUJIFILM HOLDINGS AMERICA CORPORATION | 1 | 2023 |
| MAINSTAY MEDICAL, LTD. | 1 | 2022 |
| SOFTRAMS LLC | 1 | 2022 |
| STANFORD UNIVERSITY | 1 | 2025 |
| UNITED STATES PHARMACOPEIAL CONVENTION | 1 | 2022 |
| UOFL HEALTH, INC. | 1 | 2021 |
| WCNSM ENTERPRISE, LLX | 1 | 2022 |
| YALE UNIVERSITY | 1 | 2025 |
Health Care Workforce Real-Time Data Dashboard Act
Client: SJ MEDCONNECT · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the use of real-time data information in graduate medical education, including S. 3038 - Health Care Workforce Real-Time Data Dashboard Act.
Health Care Workforce Real-Time Data Dashboard Act
Client: SJ MEDCONNECT · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the use of real-time data information in graduate medical education; Issues related to S. 3038 - Health Care Workforce Real-Time Data Dashboard Act.
Countering Weapons of Mass Destruction Extension Act of 2023
Client: SIGNATURE SCIENCE LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the authorization for the DHS Countering Weapons of Mass Destruction Office (CWMD); H.R.3224 - Countering Weapons of Mass Destruction Extension Act of 2023; S.1798 - Offices of Countering Weapons of Mass Destruction and Health Security Act of 2023.
Countering Weapons of Mass Destruction Extension Act of 2023
Client: SIGNATURE SCIENCE LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the authorization for the DHS Countering Weapons of Mass Destruction Office (CWMD); H.R.3224 - Countering Weapons of Mass Destruction Extension Act of 2023; S.1798 - Offices of Countering Weapons of Mass Destruction and Health Security Act of 2023.
Countering Weapons of Mass Destruction Extension Act of 2023
Client: SIGNATURE SCIENCE LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the authorization for the DHS Countering Weapons of Mass Destruction Office (CWMD); H.R. 3224 - Countering Weapons of Mass Destruction Extension Act of 2023; S. 1798 - Offices of Countering Weapons of Mass Destruction and Health Security Act of 2023.
Countering Weapons of Mass Destruction Extension Act of 2023
Client: SIGNATURE SCIENCE LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the authorization for the DHS Countering Weapons of Mass Destruction Office (CWMD); H.R.3224 - Countering Weapons of Mass Destruction Extension Act of 2023; S.1798 - Offices of Countering Weapons of Mass Destruction and Health Security Act of 2023.
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; H.R.4531 - Support for Patients and Communities Reauthorization Act; H.R.4099 - RECONNECTIONS Act of 2023; implementation of Fiscal Year CJS and Labor-HHS appropriations.
Issues related to behavioral health services and prescription drug monitoring programs; 988 Suicide and Crisis Lifeline; SUPPORT Act reauthorization proposals, including S.2433 - SUPPORT for Patients and Communities Reauthorization Act of 2023 and H.R.4531 - the Support for Patients and Communities Reauthorization (SUPPORT) Act of 2023; H.R. 4099 - the RECONNECTS Act of 2023; implementation of FY 2024 CJS and Labor-HHS appropriations bills; FY 2025 CJS and Labor-HHS appropriations bills.
Support for Patients and Communities Reauthorization Act
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; H.R.4531 - Support for Patients and Communities Reauthorization Act; H.R.4099 - RECONNECTIONS Act of 2023; implementation of Fiscal Year CJS and Labor-HHS appropriations.
Support for Patients and Communities Reauthorization Act
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services and prescription drug monitoring programs; 988 Suicide and Crisis Lifeline; SUPPORT Act reauthorization proposals, including S.2433 - SUPPORT for Patients and Communities Reauthorization Act of 2023 and H.R.4531 - the Support for Patients and Communities Reauthorization (SUPPORT) Act of 2023; H.R. 4099 - the RECONNECTS Act of 2023; implementation of FY 2024 CJS and Labor-HHS appropriations bills; FY 2025 CJS and Labor-HHS appropriations bills.
Women and Lung Cancer Research and Preventive Services Act of 2024
Client: QNOVIA, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues regarding smoking cessation; H.R. 4534/S.2245 - the Women and Lung Cancer Research and Preventive Services Act of 2023.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services and prescription drug monitoring programs; 988 Suicide and Crisis Lifeline; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; Implementation of FY 2024 CJS (P.L. 118-42); Implementation of FY 2024 Labor-HHS appropriations (P.L 118-47); H.R.9026/S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services and prescription drug monitoring programs; 988 Suicide and Crisis Lifeline; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; Implementation of FY 2024 CJS (P.L. 118-42); Implementation of FY 2024 Labor-HHS appropriations (P.L 118-47); H.R.9026/S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; H.R.4531 - Support for Patients and Communities Reauthorization Act; H.R.4099 - RECONNECTIONS Act of 2023; implementation of Fiscal Year CJS and Labor-HHS appropriations.
Offices of Countering Weapons of Mass Destruction and Health Security Act of 2023
Client: SIGNATURE SCIENCE LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the authorization for the DHS Countering Weapons of Mass Destruction Office (CWMD); H.R.3224 - Countering Weapons of Mass Destruction Extension Act of 2023; S.1798 - Offices of Countering Weapons of Mass Destruction and Health Security Act of 2023.
Offices of Countering Weapons of Mass Destruction and Health Security Act of 2023
Client: SIGNATURE SCIENCE LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the authorization for the DHS Countering Weapons of Mass Destruction Office (CWMD); H.R.3224 - Countering Weapons of Mass Destruction Extension Act of 2023; S.1798 - Offices of Countering Weapons of Mass Destruction and Health Security Act of 2023.
Offices of Countering Weapons of Mass Destruction and Health Security Act of 2023
Client: SIGNATURE SCIENCE LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the authorization for the DHS Countering Weapons of Mass Destruction Office (CWMD); H.R. 3224 - Countering Weapons of Mass Destruction Extension Act of 2023; S. 1798 - Offices of Countering Weapons of Mass Destruction and Health Security Act of 2023.
Offices of Countering Weapons of Mass Destruction and Health Security Act of 2023
Client: SIGNATURE SCIENCE LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the authorization for the DHS Countering Weapons of Mass Destruction Office (CWMD); H.R.3224 - Countering Weapons of Mass Destruction Extension Act of 2023; S.1798 - Offices of Countering Weapons of Mass Destruction and Health Security Act of 2023.
Women and Lung Cancer Research and Preventive Services Act of 2023
Client: QNOVIA, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues regarding smoking cessation; H.R. 4534/S.2245 - the Women and Lung Cancer Research and Preventive Services Act of 2023.
SUPPORT for Patients and Communities Reauthorization Act of 2023
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services and prescription drug monitoring programs; 988 Suicide and Crisis Lifeline; SUPPORT Act reauthorization proposals, including S.2433 - SUPPORT for Patients and Communities Reauthorization Act of 2023 and H.R.4531 - the Support for Patients and Communities Reauthorization (SUPPORT) Act of 2023; H.R. 4099 - the RECONNECTS Act of 2023; implementation of FY 2024 CJS and Labor-HHS appropriations bills; FY 2025 CJS and Labor-HHS appropriations bills.
SUPPORT for Patients and Communities Reauthorization Act
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services and prescription drug monitoring programs; 988 Suicide and Crisis Lifeline; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; Implementation of FY 2024 CJS (P.L. 118-42); Implementation of FY 2024 Labor-HHS appropriations (P.L 118-47); H.R.9026/S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025.
SUPPORT for Patients and Communities Reauthorization Act
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; H.R.4531 - Support for Patients and Communities Reauthorization Act; H.R.4099 - RECONNECTIONS Act of 2023; implementation of Fiscal Year CJS and Labor-HHS appropriations.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; H.R.4531 - Support for Patients and Communities Reauthorization Act; H.R.4099 - RECONNECTIONS Act of 2023; implementation of Fiscal Year CJS and Labor-HHS appropriations.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services and prescription drug monitoring programs; 988 Suicide and Crisis Lifeline; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; Implementation of FY 2024 CJS (P.L. 118-42); Implementation of FY 2024 Labor-HHS appropriations (P.L 118-47); H.R.9026/S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; H.R.4531 - Support for Patients and Communities Reauthorization Act; H.R.4099 - RECONNECTIONS Act of 2023; implementation of Fiscal Year CJS and Labor-HHS appropriations.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services and prescription drug monitoring programs; 988 Suicide and Crisis Lifeline; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; Implementation of FY 2024 CJS (P.L. 118-42); Implementation of FY 2024 Labor-HHS appropriations (P.L 118-47); H.R.9026/S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025.
Issues related to behavioral health services and prescription drug monitoring programs; SUPPORT Act reauthorization proposals, including S. 3393/S. 3106/S. 2433/H.R. 4531 - the SUPPORT for Patients and Communities Reauthorization Act; H.R. 4099 - the RECONNECTS Act of 2023; FY 2024 CJS and Labor-HHS appropriations bills.
Issues related to behavioral health services and prescription drug monitoring programs; SUPPORT Act reauthorization proposals, including S. 2433 - the SUPPORT for Patients and Communities Reauthorization Act of 2023, H.R. 4531 - the Support for Patients and Communities Reauthorization Act; H.R. 4099 - the RECONNECTIONS Act of 2023.
Support for Patients and Communities Reauthorization Act
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services and prescription drug monitoring programs; SUPPORT Act reauthorization proposals, including S. 2433 - the SUPPORT for Patients and Communities Reauthorization Act of 2023, H.R. 4531 - the Support for Patients and Communities Reauthorization Act; H.R. 4099 - the RECONNECTIONS Act of 2023.
Support for Patients and Communities Reauthorization Act
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services and prescription drug monitoring programs; SUPPORT Act reauthorization proposals, including S. 3393/S. 3106/S. 2433/H.R. 4531 - the SUPPORT for Patients and Communities Reauthorization Act; H.R. 4099 - the RECONNECTS Act of 2023; FY 2024 CJS and Labor-HHS appropriations bills.
SUPPORT for Patients and Communities Reauthorization Act of 2023
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services and prescription drug monitoring programs; SUPPORT Act reauthorization proposals, including S. 2433 - the SUPPORT for Patients and Communities Reauthorization Act of 2023, H.R. 4531 - the Support for Patients and Communities Reauthorization Act; H.R. 4099 - the RECONNECTIONS Act of 2023.
SUPPORT for Patients and Communities Reauthorization Act of 2023
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services and prescription drug monitoring programs; SUPPORT Act reauthorization proposals, including S. 3393/S. 3106/S. 2433/H.R. 4531 - the SUPPORT for Patients and Communities Reauthorization Act; H.R. 4099 - the RECONNECTS Act of 2023; FY 2024 CJS and Labor-HHS appropriations bills.
SUPPORT for Patients and Communities Reauthorization Act of 2023
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services and prescription drug monitoring programs; SUPPORT Act reauthorization proposals, including S. 3393/S. 3106/S. 2433/H.R. 4531 - the SUPPORT for Patients and Communities Reauthorization Act; H.R. 4099 - the RECONNECTS Act of 2023; FY 2024 CJS and Labor-HHS appropriations bills.
SUPPORT for Patients and Communities Reauthorization Act
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services and prescription drug monitoring programs; SUPPORT Act reauthorization proposals, including S. 3393/S. 3106/S. 2433/H.R. 4531 - the SUPPORT for Patients and Communities Reauthorization Act; H.R. 4099 - the RECONNECTS Act of 2023; FY 2024 CJS and Labor-HHS appropriations bills.
Honoring our PACT Act of 2022
Client: UNIVERSITY OF LOUISVILLE · Firm: AKIN GUMP STRAUSS HAUER & FELD
FY 2022 and 2023 Appropriations, including Regional Biocontainment Laboratories (RBLs), PREVENT Pandemics Act (S.3799); Honoring our PACT Act of 2022 (H.R. 3967).
FY 2022 and 2023 Appropriations, including Regional Biocontainment Laboratories (RBLs), PREVENT Pandemics Act (S.3799); Honoring our PACT Act of 2022 (H.R. 3967).
Inflation Reduction Act of 2022
Client: UNIVERSITY OF LOUISVILLE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Funding for university research opportunities via FY 2021 and 2022 federal appropriations, Infrastructure and defense authorization bills, Regional Biocontainment Laboratories (RBLs) and other federal opportunities. Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics; The Vieques Recovery and Redevelopment Act (S. 4398) and related provisions in House Build Back Better legislation (H.R. 5376); preserve charitable donations from Individual Retirement Accounts in Build Back Better legislation.
United States Innovation and Competition Act of 2021
Client: UNIVERSITY OF LOUISVILLE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Higher Education Act Reauthorization; Issues related to the Higher Education Emergency Relief Fund (HEERF); The Vieques Recovery and Redevelopment Act (S. 4398/H.R. 4605); American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations, including Regional Biocontainment Laboratories (RBLs); Endless Frontier Act/U.S. Innovation And Competition Act Of 2021 (S. 1260), and infrastructure proposals.
United States Innovation and Competition Act of 2021
Client: SYNTHETIC BIOLOGY COALITION · Firm: AKIN GUMP STRAUSS HAUER & FELD
S.1260 - United States Innovation and Competition Act of 2021
Vieques Recovery and Redevelopment Act of 2019
Client: UNIVERSITY OF LOUISVILLE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Higher Education Act Reauthorization; Issues related to the Higher Education Emergency Relief Fund (HEERF); The Vieques Recovery and Redevelopment Act (S. 4398/H.R. 4605); American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations, including Regional Biocontainment Laboratories (RBLs); Endless Frontier Act/U.S. Innovation And Competition Act Of 2021 (S. 1260), and infrastructure proposals.
Vieques Recovery and Redevelopment Act of 2020
Client: UNIVERSITY OF LOUISVILLE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Funding for university research opportunities via FY 2021 and 2022 federal appropriations, Infrastructure and defense authorization bills, Regional Biocontainment Laboratories (RBLs) and other federal opportunities. Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics; The Vieques Recovery and Redevelopment Act (S. 4398) and related provisions in House Build Back Better legislation (H.R. 5376); preserve charitable donations from Individual Retirement Accounts in Build Back Better legislation.
Vieques Recovery and Redevelopment Act of 2020
Client: UNIVERSITY OF LOUISVILLE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Higher Education Act Reauthorization; Issues related to the Higher Education Emergency Relief Fund (HEERF); The Vieques Recovery and Redevelopment Act (S. 4398/H.R. 4605); American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations, including Regional Biocontainment Laboratories (RBLs); Endless Frontier Act/U.S. Innovation And Competition Act Of 2021 (S. 1260), and infrastructure proposals.
Issues related to the use of real-time data information in graduate medical education, including S. 3038 - Health Care Workforce Real-Time Data Dashboard Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRANSMEDICS GROUP, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to organ transplantation and the organ transplantation system.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
TRANSMEDICS GROUP, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to organ transplantation and the organ transplantation system.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to the use of real-time data information in graduate medical education; Issues related to S. 3038 - Health Care Workforce Real-Time Data Dashboard Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRANSMEDICS GROUP, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · RR
Issues related to updates to the National Organ Transplant Act (NOTA) of 1984 (P.L. 98-507).
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to the use of real-time data information in graduate medical education; Issues related to S. 3038 - Health Care Workforce Real-Time Data Dashboard Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to the use of real time data when making residency position awards and awarding new residency/GME slots; Issues related to real time data information in graduate medical education.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Science & Technology Policy (OSTP), SENATE, White House Office
SIGNATURE SCIENCE LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to the authorization for the DHS Countering Weapons of Mass Destruction Office (CWMD), funding for the CWMD office, and funding for the BioWatch program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Support for the use of real time data when making residency position awards and awarding new residency/GME slots; Issues related to real time data information in graduate medical education.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Science & Technology Policy (OSTP), SENATE, White House Office
STANFORD UNIVERSITY via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to the higher education system.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Support for the use of real time data when making residency position awards and awarding new residency/GME slots; Issues related to real time data information in graduate medical education.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Science & Technology Policy (OSTP), SENATE, White House Office
YALE UNIVERSITY via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · RR
Issues related to higher education.
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2024 · fourth_quarter · Q4
Support for the use of real time data when making residency position awards and awarding new residency/GME slots.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Science & Technology Policy (OSTP), SENATE, White House Office
SIGNATURE SCIENCE LLC via AKIN GUMP STRAUSS HAUER & FELD
2024 · fourth_quarter · Q4
Issues related to the authorization for the DHS Countering Weapons of Mass Destruction Office (CWMD); H.R.3224 - Countering Weapons of Mass Destruction Extension Act of 2023; S.1798 - Offices of Countering Weapons of Mass Destruction and Health Security Act of 2023.
Issues related to the authorization for the DHS Countering Weapons of Mass Destruction Office (CWMD); H.R.3224 - Countering Weapons of Mass Destruction Extension Act of 2023; S.1798 - Offices of Countering Weapons of Mass Destruction and Health Security Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EQUIFAX INC. via AKIN GUMP STRAUSS HAUER & FELD
2024 · fourth_quarter · Q4
Issues related to Ex parte Medicaid renewals; Issues related to Equifax data hub/Work Number.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2024 · fourth_quarter · Q4
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; H.R.4531 - Support for Patients and Communities Reauthorization Act; H.R.4099 - RECONNECTIONS Act of 2023; implementation of Fiscal Year CJS and Labor-HHS appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)
LABORATORY CORPORATION OF AMERICA HOLDINGS via AKIN GUMP STRAUSS HAUER & FELD
2024 · third_quarter · Q3
Maternal and Women's health, Blueprint for Maternal Health.
Filing targets: Health & Human Services, Dept of (HHS), Indian Health Service
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2024 · third_quarter · Q3
Support for the use of real time data when making residency position awards and awarding new residency/GME slots.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Science & Technology Policy (OSTP), SENATE, White House Office
SIGNATURE SCIENCE LLC via AKIN GUMP STRAUSS HAUER & FELD
2024 · third_quarter · Q3
Issues related to the authorization for the DHS Countering Weapons of Mass Destruction Office (CWMD); H.R.3224 - Countering Weapons of Mass Destruction Extension Act of 2023; S.1798 - Offices of Countering Weapons of Mass Destruction and Health Security Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EQUIFAX INC. via AKIN GUMP STRAUSS HAUER & FELD
2024 · third_quarter · Q3
Ex parte Medicaid renewals; Equifax data hub/Work Number.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2024 · third_quarter · Q3
Issues related to behavioral health services and prescription drug monitoring programs; 988 Suicide and Crisis Lifeline; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; Implementation of FY 2024 CJS (P.L. 118-42); Implementation of FY 2024 Labor-HHS appropriations (P.L 118-47); H.R.9026/S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA), White House Office
LABORATORY CORPORATION OF AMERICA HOLDINGS via AKIN GUMP STRAUSS HAUER & FELD
2024 · second_quarter · Q2
Maternal Health Initiatives; Blueprint for Maternal Health; Ovia Health.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), White House Office
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2024 · second_quarter · Q2
Issues related to the use of real time data when making residency position awards and awarding new residency/GME slots.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Science & Technology Policy (OSTP), SENATE, White House Office
SIGNATURE SCIENCE LLC via AKIN GUMP STRAUSS HAUER & FELD
2024 · second_quarter · Q2
Issues related to the authorization for the DHS Countering Weapons of Mass Destruction Office (CWMD); H.R. 3224 - Countering Weapons of Mass Destruction Extension Act of 2023; S. 1798 - Offices of Countering Weapons of Mass Destruction and Health Security Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2024 · second_quarter · Q2
Issues related to behavioral health services and prescription drug monitoring programs; 988 Suicide and Crisis Lifeline; SUPPORT Act reauthorization proposals, including S.2433 - SUPPORT for Patients and Communities Reauthorization Act of 2023 and H.R.4531 - the Support for Patients and Communities Reauthorization (SUPPORT) Act of 2023; H.R. 4099 - the RECONNECTS Act of 2023; implementation of FY 2024 CJS and Labor-HHS appropriations bills; FY 2025 CJS and Labor-HHS appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
EQUIFAX INC. via AKIN GUMP STRAUSS HAUER & FELD
2024 · first_quarter · Q1
Issues related to Medicaid eligibility data.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QNOVIA, INC. via AKIN GUMP STRAUSS HAUER & FELD
2024 · first_quarter · Q1
Issues regarding smoking cessation; H.R. 4534/S.2245 - the Women and Lung Cancer Research and Preventive Services Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
GME residency and fellowship platforms and real-time data; awarding new residency/GME slots, use of real time data when making residency position awards.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Science & Technology Policy (OSTP), SENATE, White House Office
CITY OF LAREDO, TEXAS via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
FY 2024 appropriations and federal funding initiatives related to the City of Laredo priorities and interests including funding for transportation, housing, law enforcement, border security, homeland security, inland port issues, and health programs in FY 2024 appropriations legislation.
Issues regarding the Presidential permit process impacting the expansion of bridges to facilitate U.S.- Mexico trade, including National Defense Authorization Act for Fiscal Year 2024 (PL 118-31), Sec. 5414 - Permitting for international bridges.
Support funding of transportation and housing, law enforcement, immigration, border security, homeland security, inland port issues and health programs in FY 2023 appropriations legislation; Support binational park efforts.
LABORATORY CORPORATION OF AMERICA HOLDINGS via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
Fentanyl testing strips and use scenarios; issues related to toxicology testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
EUROAPI via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
Issues related to onshoring biopharmaceutical manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EQUIFAX INC. via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
Issues related to Medicaid eligibility data.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CONSTELLIS HOLDINGS LLC via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
Southern border vaccination policies.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
QNOVIA, INC. via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
Advocacy issues related to smoking cessation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
Issues related to behavioral health services and prescription drug monitoring programs; SUPPORT Act reauthorization proposals, including S. 3393/S. 3106/S. 2433/H.R. 4531 - the SUPPORT for Patients and Communities Reauthorization Act; H.R. 4099 - the RECONNECTS Act of 2023; FY 2024 CJS and Labor-HHS appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FUJIFILM HOLDINGS AMERICA CORPORATION via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · RR
Support for biopharmaceutical manufacturing in the U.S.
CONSTELLIS HOLDINGS LLC via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · RR
Provide policy counsel to client on Customs and Border Protection and Department of Homeland Security vaccination contracts/opportunities.
ABBOTT LABORATORIES via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Strategic and policy advice related to general healthcare issues; issues related to COVID-19 testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
GME residency and fellowship platforms and real-time data; awarding new residency/GME slots, use of real time data when making residency position awards.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Science & Technology Policy (OSTP), SENATE, White House Office
EQUIFAX INC. via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Issues related to Medicaid eligibility data.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Fentanyl testing strips and use scenarios; issues related to toxicology testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT), White House Office
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Issues related to behavioral health services and prescription drug monitoring programs; SUPPORT Act reauthorization proposals, including S. 2433 - the SUPPORT for Patients and Communities Reauthorization Act of 2023, H.R. 4531 - the Support for Patients and Communities Reauthorization Act; H.R. 4099 - the RECONNECTIONS Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EUROAPI via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Issues related to onshoring biopharmaceutical manufacturing.
Issues related to onshoring biopharmaceutical manufacturing.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
QNOVIA, INC. via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · RR
Smoking cessation.
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
GME residency and fellowship platforms and real-time data; awarding new residency/GME slots, use of real time data when making residency position awards.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Science & Technology Policy (OSTP), SENATE, White House Office
LABORATORY CORPORATION OF AMERICA HOLDINGS via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Fentanyl testing strips and use scenarios.
Filing targets: Centers For Disease Control & Prevention (CDC), Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Transportation, Dept of (DOT)
EUROAPI via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Issues related to onshoring biopharmaceutical manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2023 · first_quarter · Q1
GME residency and fellowship platforms and real-time data; awarding new residency/GME slots, use of real time data when making residency position awards.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
INARI MEDICAL via AKIN GUMP STRAUSS HAUER & FELD
2023 · first_quarter · Q1
Education and awareness of medical device treatments for blood clots.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EUROAPI via AKIN GUMP STRAUSS HAUER & FELD
2023 · first_quarter · RR
Onshoring biomanufacturing of pharmaceutical precursors.
Onshoring biomanufacturing of pharmaceutical precursors.
Onshoring biomanufacturing of pharmaceutical precursors.
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · Q4
GME residency and fellowship platforms and real-time data.
GME residency and fellowship platforms and real-time data.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · Q4
Medical supply chain issues and supply chain integrity; advanced manufacturing; cannabis.
Medical supply chain issues and supply chain integrity; advanced manufacturing; cannabis.
Filing targets: HOUSE OF REPRESENTATIVES
SUNNY GLEN CHILDREN'S HOME via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · Q4
Issues related to Office of Refugee Resettlement and clients foster care and housing services.
Filing targets: Health & Human Services, Dept of (HHS)
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2022 · first_quarter · RA
Issues related to health care coordination, mental health, behavioral health, and substance use disorder.
Issues related to health care coordination, mental health, behavioral health, and substance use disorder.
Issues related to health care coordination, mental health, behavioral health, and substance use disorder.
WCNSM ENTERPRISE, LLX via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · RR
Identify and pursue federal funding of new air purification and disinfection systems.
Identify and pursue federal funding of new air purification and disinfection systems.
Identify and pursue federal funding of new air purification and disinfection systems.
ABBOTT LABORATORIES via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · 2A
Strategic and policy advice related to health care issues, including COVID-19 legislation and regulations; monitor telehealth developments, appropriations, and other issues related to health care diagnostics; outreach and advocacy for future pandemic preparedness.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SYNTHETIC BIOLOGY COALITION via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · Q3
Issues related to the investment and commercialization of synthetic biology applications; House and Senate FY 2022 appropriations; USICA and America COMPETES.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · Q3
GME residency and fellowship platforms and real-time data.
GME residency and fellowship platforms and real-time data.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BRADLEY LANE INVESTMENT COMPANY via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · Q3
Location of ARPA-H.
Location of ARPA-H.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AHS MANAGEMENT COMPANY, INC via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · Q3
Issues related to American Rescue Plan Act Provider Relief Fund Rural Payment Distribution.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · Q3
Issues related to mental and behavioral health services and prescription drug monitoring programs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
CENTRIENT PHARMACEUTICALS LLC via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · Q3
Advocacy regarding solutions for onshoring supply chain and manufacturing of essential medicines in the United States.; Issues related to health care supply chain and Mexico regulatory delays.
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · RR
Lobby for the use of real-time information in residency slot distribution and demographic information when awarding GME slots by CMS.
AHS MANAGEMENT COMPANY, INC via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · RR
Issues related to Provider Relief Fund Rural Payments.
SYNTHETIC BIOLOGY COALITION via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · Q2
Issues related to the investment and commercialization of synthetic biology applications; House and Senate FY 2022 appropriations; USICA and America COMPETES.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SOFTRAMS LLC via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · Q2
Issues related to Medicare and Medicaid program implementation.
Filing targets: Bureau of Citizenship & Immigration Services (BCIS), Centers For Medicare and Medicaid Services (CMS)
CENTRIENT PHARMACEUTICALS LLC via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · Q2
Advocacy regarding solutions for onshoring supply chain and manufacturing of essential medicines back to the United States.; Issues related to health care supply chain and Mexico regulatory delays.
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · Q2
Strategic and policy advice related to health care issues, including COVID-19 legislation and regulations; monitor telehealth developments, appropriations, and other issues related to health care diagnostics; outreach and advocacy for future pandemic preparedness.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNIVERSITY OF LOUISVILLE via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · Q2
FY 2022 and 2023 Appropriations, including Regional Biocontainment Laboratories (RBLs), PREVENT Pandemics Act (S.3799); Honoring our PACT Act of 2022 (H.R. 3967).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · Q2
Issues related to behavioral health services and prescription drug monitoring programs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
EMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · Q2
Advocacy related to COVID-19 testing services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
BRADLEY LANE INVESTMENT COMPANY via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · RR
Location of ARPA-H.
Location of ARPA-H.
SUNNY GLEN CHILDREN'S HOME via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · RR
Federal outreach to Congress/Executive Branch regarding adoption and foster care policies.
GAP INC. via AKIN GUMP STRAUSS HAUER & FELD
2022 · first_quarter · Q1
Section 301 tariffs; Generalized System of Preferences modernization; CAFTA modernization; COVID-19 vaccine allocations
COVID vaccine distribution
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID)
ABBOTT LABORATORIES via AKIN GUMP STRAUSS HAUER & FELD
2022 · first_quarter · Q1
Strategic and policy advice related to health care issues, including COVID-19 legislation and regulations; monitor telehealth developments, appropriations, and other issues related to health care diagnostics; outreach and advocacy for future pandemic preparedness.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE
EMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2022 · first_quarter · Q1
Advocacy related to COVID-19 testing services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
SYNTHETIC BIOLOGY COALITION via AKIN GUMP STRAUSS HAUER & FELD
2022 · first_quarter · Q1
Issues related to the investment and commercialization of synthetic biology applications; House and Senate FY 2022 appropriations.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MAINSTAY MEDICAL, LTD. via AKIN GUMP STRAUSS HAUER & FELD
2022 · first_quarter · RR
Advocacy related to non-opioid pain management devices.
Advocacy related to non-opioid pain management devices.
INFINEON TECHNOLOGIES AMERICA CORP. via AKIN GUMP STRAUSS HAUER & FELD
2021 · third_quarter · 3A
Domestication of semiconductor manufacturing capacity.
Domestication of semiconductor manufacturing capacity.
Domestication of semiconductor manufacturing capacity.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INFINEON TECHNOLOGIES AMERICA CORP. via AKIN GUMP STRAUSS HAUER & FELD
2021 · third_quarter · Q3
Domestication of semiconductor manufacturing capacity.
Domestication of semiconductor manufacturing capacity.
Domestication of semiconductor manufacturing capacity.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INFINEON TECHNOLOGIES AMERICA CORP. via AKIN GUMP STRAUSS HAUER & FELD
2021 · third_quarter · Q3
Semi conductor manufacturer.
Domestication of semiconductor manufacturing capacity.
Semi conductor manufacturer.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UOFL HEALTH, INC. via AKIN GUMP STRAUSS HAUER & FELD
2021 · fourth_quarter · Q4
COVID-19 pandemic response and provider funding; American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations; Wastewater surveillance; infrastructure and budget reconciliation legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
UNIVERSITY OF LOUISVILLE via AKIN GUMP STRAUSS HAUER & FELD
2021 · fourth_quarter · Q4
Funding for university research opportunities via FY 2021 and 2022 federal appropriations, Infrastructure and defense authorization bills, Regional Biocontainment Laboratories (RBLs) and other federal opportunities. Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
SYNTHETIC BIOLOGY COALITION via AKIN GUMP STRAUSS HAUER & FELD
2021 · fourth_quarter · Q4
Issues related to the investment and commercialization of synthetic biology applications; House and Senate FY 2022 appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
LABORATORY CORPORATION OF AMERICA HOLDINGS via AKIN GUMP STRAUSS HAUER & FELD
2021 · fourth_quarter · Q4
Nonhuman primate supply chain issues/China export ban.
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, U.S. Trade Representative (USTR), White House Office
INARI MEDICAL via AKIN GUMP STRAUSS HAUER & FELD
2021 · fourth_quarter · Q4
Education and awareness of medical device treatments for blood clots.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
GAP INC. via AKIN GUMP STRAUSS HAUER & FELD
2021 · fourth_quarter · Q4
Section 301 tariffs; Generalized System of Preferences modernization; CAFTA modernization; COVID-19 vaccine allocations
COVID vaccine distribution
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID)
EMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2021 · fourth_quarter · Q4
Advocacy related to COVID-19 testing services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
EMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2021 · fourth_quarter · RR
COVID-19 testing.
COVID-19 testing.
LABORATORY CORPORATION OF AMERICA HOLDINGS via AKIN GUMP STRAUSS HAUER & FELD
2021 · third_quarter · Q3
Nonhuman primate supply chain issues/China export ban
Nonhuman primate supply chain issues/China export ban
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, U.S. Trade Representative (USTR), White House Office
INARI MEDICAL via AKIN GUMP STRAUSS HAUER & FELD
2021 · third_quarter · Q3
Defense Production Act allocation of catheter supply chain issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GAP INC. via AKIN GUMP STRAUSS HAUER & FELD
2021 · third_quarter · Q3
Section 301 tariffs; Generalized System of Preferences modernization; CAFTA modernization; COVID-19 vaccine allocations
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
UNIVERSITY OF LOUISVILLE via AKIN GUMP STRAUSS HAUER & FELD
2021 · third_quarter · Q3
Funding for university research opportunities via FY 2021 and 2022 federal appropriations, Infrastructure and defense authorization bills, Regional Biocontainment Laboratories (RBLs) and other federal opportunities. Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics; The Vieques Recovery and Redevelopment Act (S. 4398) and related provisions in House Build Back Better legislation (H.R. 5376); preserve charitable donations from Individual Retirement Accounts in Build Back Better legislation.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
SYNTHETIC BIOLOGY COALITION via AKIN GUMP STRAUSS HAUER & FELD
2021 · third_quarter · Q3
Issues related to the investment and commercialization of synthetic biology applications; House and Senate FY 2022 appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
SYNTHETIC BIOLOGY COALITION via AKIN GUMP STRAUSS HAUER & FELD
2021 · second_quarter · Q2
Issues related to the investment and commercialization of synthetic biology applications.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
UNIVERSITY OF LOUISVILLE via AKIN GUMP STRAUSS HAUER & FELD
2021 · second_quarter · Q2
Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics; American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations, including Regional Biocontainment Laboratories (RBLs).
Higher Education Act Reauthorization; Issues related to the Higher Education Emergency Relief Fund (HEERF); The Vieques Recovery and Redevelopment Act (S. 4398/H.R. 4605); American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations, including Regional Biocontainment Laboratories (RBLs); Endless Frontier Act/U.S. Innovation And Competition Act Of 2021 (S. 1260), and infrastructure proposals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
SYNTHETIC BIOLOGY COALITION via AKIN GUMP STRAUSS HAUER & FELD
2021 · second_quarter · RR
S.1260 - United States Innovation and Competition Act of 2021
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2020 · first_quarter · RR
Issues related to health care coordination, mental health, behavioral health, and substance use disorder.
Issues related to health care coordination, mental health, behavioral health, and substance use disorder.
Issues related to health care coordination, mental health, behavioral health, and substance use disorder.
Federal funding initiatives related to the City of Laredo priorities and interests. Issues related to the Presidential permitting process, including National Defense Authorization Act for Fiscal Year 2024 (PL 118-31), Sec. 5414 - Permitting for international bridges.
Issues related to infrastructure funding and permitting for infrastructure related projects.
Filing targets: HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Natl Park Service (NPS), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), White House Office
Identify and pursue federal funding of new air purification and disinfection systems.